Development of continuous implantable renal replacement: past and future

Translational Research

Volumn 150, Issue 6, 2007, Pages 327-336

  Fissell, William H ^a   Fleischman, Aaron J ^a   Humes, H David ^b   Roy, Shuvo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; POLYMER; SILICON;

ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CELL GROWTH; CYTOTOXICITY; DEFIBRILLATOR; DIALYSIS; DIFFUSION; EXTRACORPOREAL CIRCULATION; FLUID TRANSPORT; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY CELL; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; MEMBRANE PERMEABILITY; MEMBRANE TECHNOLOGY; METABOLISM; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; THERMODYNAMICS; TISSUE ENGINEERING;

EID: 36049035646     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.06.001     Document Type: Review

References (43)

1. Hsu C.-Y., Vittinghoff E., Lin F., and Shlipak M.G. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Internal Med 141 (2004) 95-101
2. U.S. Preventive Services Task Force. The guide to clinical preventive services 2006.U.S. Department of Health and Human Services Agency for Healthcare Research and Quality AHRQ. Publication 06-0588.
3. U.S. Renal Data System. USRDS 2006 annual data report: Atlas of end-stage renal disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md
4. ™ guidelines (2006), National Kidney Foundation, New York
5. Pierratos A., McFarlane P., and Chan C.T. Quotidian dialysis update 2005. Curr Opin Nephrol Hypertens 14 (2005) 119-124
6. Chan C.T., Floras J.S., Miller J.A., Richardson R.M., and Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61 (2002) 2235
7. Lindsay R.M., Alhejaili F., Nesrallah G., et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42 suppl 1 (2003) 24
8. Heidenheim A.P., Muirhead N., Moist L., and Lindsay R.M. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 42 suppl 1 (2003) 36
9. Schlaeper C., and Diaz-Buxo J.A. Home hemodialysis and remote monitoring: current technology, requirements, and capabilities. Blood Purif 23 (2005) 18-22
10. Ledebo I. Convective dialysis therapies, current status and perspective. Ther Apher Dial 9 (2005) 223
11. Padrini R., Canova C., Conz P., Mancini E., Rizzioli E., and Santoro A. Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration. Kidney Int 68 (2005) 2331
12. Krieter D.H., Lemke H.D., Canaud B., and Wanner C. Beta(2)-microglobulin removal by extracorporeal renal replacement therapies. Biochim Biophys Acta 1753 (2005) 146
13. Beerenhout C.H., Luik A.J., Jeuken-Mertens S.G., et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 20 (2005) 1155
14. Gura V., Beizai M., Ezon C., and Polaschegg H.D. Continuous renal replacement therapy for end-stage renal disease. The wearable artificial kidney (WAK). Contrib Nephrol 149 (2005) 325
15. Leonard E.F., West A.C., Shapley N.C., and Larsen M.U. Dialysis without membranes: how and why?. Blood Purif 22 (2004) 92
16. Leonard E.F., Cortell S., and Vitale N.G. Membraneless dialysis-is it possible?. Contrib Nephrol 149 (2005) 343
17. Nissenson A.R., Ronco C., Pergamit G., Edelstein M., and Watts R. The human nephron filter: Toward a continuously functioning, implantable artificial nephron system. Blood Purif 23 (2005) 269
18. Nissenson A.R., Ronco C., Pergamit G., Edelstein M., and Watts R. Continuously functioning artificial nephron system: the promise of nanotechnology. Hemodial Int 9 (2005) 210
19. Koh C.J., and Atala A. Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 15 (2004) 1113
20. Humes H.D., Buffington D.A., Mackay S.M., Funke A.J., and Weitzel W.F. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nature Biotechnol 17 (1999) 451-455
21. Humes H.D., Weitzel W.F., Bartlett R.H., et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 66 (2004) 1578-1588
22. Humes H.D. Bioartificial kidney for full renal replacement therapy. Semin Nephrol 20 (2000) 71
23. Tumlin J., Wali R., Brennan K., and Humes H.D. Effect of the renal assist device (RAD) on mortality of dialysis-dependent acute renal failure: a randomized, open-labeled, multicenter, Phase II trial. J Am Soc Nephrol 16 (2005) 46A
24. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
25. Annane D., Sébille V., Bellissant E., and Ger-Inf-05 Study Group. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862
26. Ross E.A., Briz C., and Sadleir R.J. Method for detecting the disconnection of an extracorporeal device using a patient's endogenous electrical voltages. Kid Int 69 (2006) 2274-2277
27. Ronco C., and Bowry S. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. IJAO 24 (2001) 726-735
28. Nath P., Roy S., Conlisk T., and Fleischman A.J. A system for micro/nano fluidic flow diagnostics. Biomed Microdevices 7 (2005) 169-177
29. Toner M., and Irimia D. Blood-on-a-chip. Ann Rev Biomed Engin 7 (2005) 77-103
30. Chen C.S., Alonso J.L., Ostuni E., Whitesides G.M., and Ingber D.E. Cell shape provides global control of focal adhesion assembly. Biochemical and Biophysical Research Communications 307 (2003) 355-361
31. Chen C.S., Mrksich M., Huang S., Whitesides G.M., and Ingber D.E. Geometric control of cell life and death. Science 276 (1997) 1425-1428
32. Desai T.A., West T., Cohen M., Boiarski T., and Rampersaud A. Nanoporous. Microsystems for islet cell replacement. Adv Drug Delivery Rev 56 (2004) 1661-1673
33. Fissell W.H., Humes H.D., Roy S., and Fleischman A. Initial characterization of a nanoengineered ultrafiltration membrane. Am Soc Nephrol 13 (2002) 602A
34. Magistrelli J.M. Investigating fluid flow through silicon nanoporous membranes (2004), Case Western Reserve University, Cleveland, Ohio Master's thesis
35. Papra A., Gadegaard N., and Larson N.B. Characterization of ultrathin poly(ethylene glycol) monolayers on silicon substrates. Langmuir 17 (2001) 1457-1460
36. Ohlson M., Sörensson J., and Haraldsson B. Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin. Am J Physiol Renal Physiol 279 (2000) F84-F91
37. Humes H.D., MacKay S.M., Funke A.J., and Buffington D.A. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kid Int 55 (1999) 2502-2514
38. Fissell W.H., Manley S., Westover A., Humes H.D., Fleischman A.J., and Roy S. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J 52 (2006) 221-227
39. Shettigar U.R., Kablitz C., Stephen R., and Kolff W.J. A portable hemodialysis/hemofiltration system independent of dialysate and infusion fluid. Artif Organs 7 (1983) 254-256
40. Stephen R.L., Jacobsen S.C., Kablitz C., and Kolff W.J. Combined technological-clinical approach to wearable dialysis. Kid Int 8 suppl (1978) S125-S132
41. Kim Y.J., Kang I.K., Huh M.W., and Yoon S.C. Surface characterization and in vitro blood compatibility of poly(ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials 21 (2000) 121-130
42. Holland N.B., Qiu Y., Ruegsegger M., and Marchant R.E. Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers. Nature 392 (1998) 799-801
43. Frost M.C., Reynolds M.M., and Meyerhoff M.E. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 26 (2005) 1685-1693